Dr Jean-Paul SALMON
Chef de Service - Oncologue
Chef de Service - Oncologue
Oncologue
Spécialités
- ONCOLOGIE MEDICALE
Consultations et rendez-vous
Services
Planning des consultations
Site Laveu
Rue des Wallons 72, 4000, Liège
Matin
Après-midi
Lundi
Matin
Après-midi
Mardi
Matin
Après-midi
Mercredi
Matin
Après-midi
Jeudi
Matin
Après-midi
Vendredi
Matin
Après-midi
Samedi
Matin
Après-midi
Site Citadelle
Boulevard du 12e de Ligne 1, 4000, Liège
Matin
Après-midi
Lundi
Matin
Après-midi
Mardi
Matin
Après-midi
Mercredi
Matin
Après-midi
Jeudi
Matin
Après-midi
Vendredi
Matin
Après-midi
Samedi
Matin
Après-midi
Présentation
- Consultation d'Oncologie médicale, en particulier d'oncologie mammaire et mélanome
- Hospitalisation de jour pour les chimiothérapies, transfusions et tous traitements intraveineux
- Participation aux réunions multidisciplinaires oncologiques
- Développement de la Clinique du Sein
- Membre :
- De l'International Breast Cancer Study Group (IBCSG)
- d’un groupe local d’évaluation médicale (GLEM) en Oncologie
- de la Belgian Society of Oncology (BSMO)
- de l’European Society of Medical Oncology (ESMO)
- de l’American Society of Clinical Oncology (ASCO)
Publications
- [Degeneration of a congenital pulmonary adenomatoid cyst and ventricular trigeminism of adulte age. Is there a cause-and-effect relationship?] In french.
JP. Salmon, V. Corbion-Jossa, M. Guiot-Ramaut
Rev.Pneumol.Clin., 1997, 53, 33-36.
- Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood stem cell transplantation.
JP. Salmon, S. Michaux, J-Ph. Hermanne, E. Baudoux, Ch. Gérard, D. Sondag-Thull, G. Fillet, Y. Beguin
Transfusion, 1998, 39, 824-827.
- Clinical course and predictive factors for Cyclosporine - induced autologous graft - versus - host disease after autologous hematopoietic stem cell transplatation (HSCT).
F. Baron, A. Gothot, JP. Salmon, J-Ph. Hermanne, G.E. Pierard, G. Fillet, Y. Beguin
Br J Haematol, 2000 Dec, 111 (3); 745-753.
- Administration of rHuEPO and G-CSF in donor / recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogenic PBPC transplantation.
Brieux Sautois*, Etienne Baudoux°, Jean Paul Salmon*, Sandrine Michaux*, Nicole Schaaf-Lafontaine#, Maguy Pereira*, Jean-Michel Paulus#, Georges Fillet*, Yves Beguin*. Department of Medecine, Division of Haematology, Department of Transfusion Medecine, Department of Clinical Biology Division of Laboratory Haematology#, University of Liège, Liège, Belgium
Haematologica, 2001,86, 1209-1218.
- Sequencial Administration of Epirubicin and Paclitaxel for Advanced Breast Cancer.A Phase I Randomized Trial.
C. Focan, MP Graas, M. Bauduin, J-L. Canon, JP. Salmon, G. Jerusalem, D. Focan- Henrard, JP. Lobelle and D. Schallier
Anticancer research, 2005, 25, 1211-1218.
- Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy.
C.Bovy, E. Baudoux, JP. Salmon, Y. Beguin
Transfusion, 2006, 46, 1616-1623.
- Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): A multicentre, open-label, randomised, phase 3 trial
Marco Colleoni, Weixiu Luo, Per Karlsson, all 252 authors
The Lancet Oncology, November 2017 10.1016/S1470-2045(17)30715-5
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast
cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Miguel Martin,Frankie Ann Holmes, Bent Ejlertsen, all 622 authors, Mahmoud Charif
The Lancet Oncology, November 2017 10.1016/S1470-2045(17)30717-9
- Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (>20%) FN-risk chemotherapy:
results from a prospective observational study.
Jean Paul Salmon1, Martin Smakal2, Charisios Karanikiotis3, Marek Z.
Wojtukiewicz4, Yohann Omnes5, Lucy DeCosta5, Sally Wetten6, James O’Kelly6
1Centre Hospitalier Régional de la Citadelle, Medical Oncology, Liège, Belgium ;
2Nemocnice Hořovice Hospital, Hořovice, Czech Republic; 3424 Army General
Hospital, Thessaloniki, Greece; 4Medical University, Comprehensive Cancer Center,
Bialystok, Poland; 5Amgen Biostatistical Sciences, Uxbridge, UK; 6Amgen Center for
Observational Research, Uxbridge, UK.
Supportive Care in Cancer, 26 09 2018, 1-9
- Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon Jordan, Petit Coralie, Moreau Marie, Bertrand Toutain, Roché Henri,
Bonichon-Lamichhane Nathalie, Salmon JP, Lemonnier Jérôme, Campone Mario,
Verrièle Véronique, Lelièvre Eric, Guette Catherine and Coqueret Olivier
Cell death and desease, feb 2019 10 ;199
- Prise en charge d’un myélome multiple chez une patiente âgée aux antécédents de néoplasie mammaire : illustration de l’intérêt d’une collaboration multidisciplinaire.
A multiple myeloma in an elderly patient with a history of breast cancer: illustration of
the value of multidisciplinary collaboration
Legros M, Bouillon AS, Janin N, Moonen M, Louviaux I, Salmon JP, Berg N, Servais P
Revue Médicale de Liège, Avril 2021